The Multi Cancer Early Detection market is expected to grow from USD 872.36 million in 2022 to USD 3,420.25 million by 2032, at a CAGR of 14.64% during the forecast period 2023-2032.
Multiple cancer early detection (MECD) is a diagnostic technique to detect different types of cancer in the body. MECD tests for cancer are generally performed by collecting blood samples, genetics, liquid biopsy, LTD and other samples. Multiple cancer early detection (MECD) tests help doctors check the risk of cancer cells multiplying in blood vessels, throat, colon, epidermis, lungs, and other body parts. MCED aims to detect tumours in the body.
The increasing cancer rates, rising understanding of cancer, and increasing government focus on early cancer detection are driving the growth of the multi-cancer early detection market. On the other hand, costly testing for cancer, adverse health effects and the need for advanced machines are hindering the market's growth. Moreover, rising alcohol consumption & smoking, high cholesterol levels and obesity are anticipated to fuel the market's growth over the forecast year. However, false negative results and a lack of skilled medical professionals can challenge the market growth over the forecast period.
This study comprehensively analyses type, end-use, and region. The type segment includes liquid biopsy, gene panel, LDT and others. The gene panel segment registered the largest market share in 2022 owing to the growing awareness of hereditary cancers and increasing understanding of genetic tests. The gene panels are mainly focusing on detecting hereditary cancers. As a result, there is a hike in genetic tests that can detect cancers at an early stage to improve patient survival. The end-use segment is divided into diagnostic laboratories, hospitals and others. The hospitals segment held the largest market share in 2022 because of the large number of specialized physicians and health personnel involved in the diagnosis and treatment in hospitals. A hospital is a medium to educate and raise awareness of specific diseases and conditions. Multi-cancer early detection is a novel technology that the target audience needs to understand. Therefore, multiple examinations are performed on asymptomatic patients in the hospital to facilitate the treatment.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The Europe region held the highest market revenue in 2022 due to the rising cancer rates and rising investments in R&D by the governments and market players in the region. The North American region is expected to witness the quickest growth during the forecast year owing to the growing cancer incidence.
Some of the notable players in the market are Grail, LLC (Illumina, Inc.), Exact Sciences Corporation., Foundation Medicine, Inc., AnchorDx, Guardant Health, Inc., Burning Rock Biotech Limited, GENECAST, Laboratory for Advanced Medicine, Inc. and Singlera Genomics Inc. among others.
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Type
4.3.2. Market Attractiveness Analysis By End-use
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Market Evaluation
5.3. Drivers
5.3.1. Increasing prevalence of cancer
5.4. Restraints
5.4.1. The expensive testing
5.5. Opportunities
5.5.1. The rise in smoking, drinking, obesity, elevated cholesterol levels, and exposure to harmful radiation
5.6. Challenges
5.6.1. Lack of skilled medical professionals
6. Global Multi Cancer Early Detection Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Liquid Biopsy
6.3. Gene Panel
6.4. LDT
6.5. Others
7. Global Multi Cancer Early Detection Market Analysis and Forecast, By End-use
7.1. Segment Overview
7.2. Diagnostic Laboratories
7.3. Hospitals
7.4. Others
8. Global Multi Cancer Early Detection Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Multi Cancer Early Detection Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Multi Cancer Early Detection Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Grail, LLC (Illumina, Inc.)
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Exact Sciences Corporation.
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Foundation Medicine, Inc.
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. AnchorDx
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Guardant Health, Inc.
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Burning Rock Biotech Limited
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. GENECAST
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Laboratory for Advanced Medicine, Inc.
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Singlera Genomics Inc.
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
List of Table
1. Global Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
2. Global Liquid Biopsy, Multi Cancer Early Detection Market, By Region, 2019-2032 (USD Million)
3. Global Gene Panel, Multi Cancer Early Detection Market, By Region, 2019-2032 (USD Million)
4. Global LDT, Multi Cancer Early Detection Market, By Region, 2019-2032 (USD Million)
5. Global Others, Multi Cancer Early Detection Market, By Region, 2019-2032 (USD Million)
6. Global Multi Cancer Early Detection Market, By End-use, 2019-2032 (USD Million)
7. Global Diagnostic Laboratories, Multi Cancer Early Detection Market, By Region, 2019-2032 (USD Million)
8. Global Hospitals, Multi Cancer Early Detection Market, By Region, 2019-2032 (USD Million)
9. Global Others, Multi Cancer Early Detection Market, By Region, 2019-2032 (USD Million)
10. North America Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
11. North America Multi Cancer Early Detection Market, By End-use, 2019-2032 (USD Million)
12. U.S. Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
13. U.S. Multi Cancer Early Detection Market, By End-use, 2019-2032 (USD Million)
14. Canada Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
15. Canada Multi Cancer Early Detection Market, By End-use, 2019-2032 (USD Million)
16. Mexico Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
17. Mexico Multi Cancer Early Detection Market, By End-use, 2019-2032 (USD Million)
18. Europe Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
19. Europe Multi Cancer Early Detection Market, By End-use, 2019-2032 (USD Million)
20. Germany Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
21. Germany Multi Cancer Early Detection Market, By End-use, 2019-2032 (USD Million)
22. France Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
23. France Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
24. U.K. Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
25. U.K. Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
26. Italy Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
27. Italy Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
28. Spain Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
29. Spain Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
30. Asia Pacific Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
31. Asia Pacific Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
32. Japan Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
33. Japan Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
34. China Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
35. China Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
36. India Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
37. India Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
38. South America Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
39. South America Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
40. Brazil Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
41. Brazil Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
42. Middle East and Africa Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
43. Middle East and Africa Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
44. UAE Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
45. UAE Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million)
46. South Africa Multi Cancer Early Detection Market, By Type, 2019-2032 (USD Million)
47. South Africa Multi Cancer Early Detection Market, By End-use 2019-2032 (USD Million) (K Units
List of Figures
1. Global Multi Cancer Early Detection Market Segmentation
2. Global Multi Cancer Early Detection Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Multi Cancer Early Detection Market Attractiveness Analysis By Type
9. Global Multi Cancer Early Detection Market Attractiveness Analysis By End-use
10. Global Multi Cancer Early Detection Market Attractiveness Analysis By Region
11. Global Multi Cancer Early Detection Market: Dynamics
12. Global Multi Cancer Early Detection Market Share By Type (2023 & 2032)
13. Global Multi Cancer Early Detection Market Share By End-use (2023 & 2032)
14. Global Multi Cancer Early Detection Market Share By Regions (2023 & 2032)
15. Global Multi Cancer Early Detection Market Share By Company (2022)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.